A citation-based method for searching scientific literature

Julia R Trosman, Christine B Weldon, Anne Slavotinek, Mary E Norton, Michael P Douglas, Kathryn A Phillips. Genet Med 2020
Times Cited: 18







List of co-cited articles
83 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
Michelle M Clark, Zornitza Stark, Lauge Farnaes, Tiong Y Tan, Susan M White, David Dimmock, Stephen F Kingsmore. NPJ Genom Med 2018
150
33

Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
Michael P Douglas, Stephanie L Parker, Julia R Trosman, Anne M Slavotinek, Kathryn A Phillips. Genet Med 2019
14
35

Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Siddharth Srivastava, Jamie A Love-Nichols, Kira A Dies, David H Ledbetter, Christa L Martin, Wendy K Chung, Helen V Firth, Thomas Frazier, Robin L Hansen, Lisa Prock,[...]. Genet Med 2019
98
22

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Kathryn A Phillips, Patricia A Deverka, Gillian W Hooker, Michael P Douglas. Health Aff (Millwood) 2018
67
22

Payer coverage policies for multigene tests.
Kathryn A Phillips, Patricia A Deverka, Julia R Trosman, Michael P Douglas, James D Chambers, Christine B Weldon, Andrew P Dervan. Nat Biotechnol 2017
25
22

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
Julia R Trosman, Christine B Weldon, Michael P Douglas, Allison W Kurian, R Kate Kelley, Patricia A Deverka, Kathryn A Phillips. J Natl Compr Canc Netw 2017
23
16

Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
Julia R Trosman, Christine B Weldon, R Kate Kelley, Kathryn A Phillips. J Natl Compr Canc Netw 2015
28
16

Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
Chloe M Reuter, Jennefer N Kohler, Devon Bonner, Diane Zastrow, Liliana Fernandez, Annika Dries, Shruti Marwaha, Jean Davidson, Elly Brokamp, Matthew Herzog,[...]. J Genet Couns 2019
11
27

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
James D Chambers, Cayla J Saret, Jordan E Anderson, Patricia A Deverka, Michael P Douglas, Kathryn A Phillips. Int J Technol Assess Health Care 2017
14
21

Reanalysis of Clinical Exome Sequencing Data.
Pengfei Liu, Linyan Meng, Elizabeth A Normand, Fan Xia, Xiaofei Song, Andrew Ghazi, Jill Rosenfeld, Pilar L Magoulas, Alicia Braxton, Patricia Ward,[...]. N Engl J Med 2019
59
16

Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource.
Natasha T Strande, Erin Rooney Riggs, Adam H Buchanan, Ozge Ceyhan-Birsoy, Marina DiStefano, Selina S Dwight, Jenny Goldstein, Rajarshi Ghosh, Bryce A Seifert, Tam P Sneddon,[...]. Am J Hum Genet 2017
188
16

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
799
16

Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.
Iván Sánchez Fernández, Tobias Loddenkemper, Marina Gaínza-Lein, Beth Rosen Sheidley, Annapurna Poduri. Neurology 2019
27
16

Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.
Andres Moreno-De-Luca, Scott M Myers, Thomas D Challman, Daniel Moreno-De-Luca, David W Evans, David H Ledbetter. Lancet Neurol 2013
169
16

Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Darrel Waggoner, Karen E Wain, Adrian M Dubuc, Laura Conlin, Scott E Hickey, Allen N Lamb, Christa Lese Martin, Cynthia C Morton, Kristen Rasmussen, Jane L Schuette,[...]. Genet Med 2018
17
17


Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders.
Mari Rossi, Dima El-Khechen, Mary Helen Black, Kelly D Farwell Hagman, Sha Tang, Zöe Powis. Pediatr Neurol 2017
41
16

Clinical whole-exome sequencing results impact medical management.
Nancy Niguidula, Christina Alamillo, Layla Shahmirzadi Mowlavi, Zöe Powis, Julie S Cohen, Kelly D Farwell Hagman. Mol Genet Genomic Med 2018
18
16

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
16


Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
David T Miller, Margaret P Adam, Swaroop Aradhya, Leslie G Biesecker, Arthur R Brothman, Nigel P Carter, Deanna M Church, John A Crolla, Evan E Eichler, Charles J Epstein,[...]. Am J Hum Genet 2010
16


Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.
Andrew P Dervan, Patricia A Deverka, Julia R Trosman, Christine B Weldon, Michael P Douglas, Kathryn A Phillips. Genet Med 2017
14
14

What is the clinical utility of genetic testing?
Scott D Grosse, Muin J Khoury. Genet Med 2006
171
11

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Julia R Trosman, Christine B Weldon, William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, James M Ford, Alan Balch, John Watkins, Kathryn A Phillips. Value Health 2018
9
22

The efficacy of diagnostic imaging.
D G Fryback, J R Thornbury. Med Decis Making 1991
832
11

Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
Konstantinos N Lazaridis, Kimberly A Schahl, Margot A Cousin, Dusica Babovic-Vuksanovic, Douglas L Riegert-Johnson, Ralitza H Gavrilova, Tammy M McAllister, Noralane M Lindor, Roshini S Abraham, Michael J Ackerman,[...]. Mayo Clin Proc 2016
59
11

Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.
Lauge Farnaes, Amber Hildreth, Nathaly M Sweeney, Michelle M Clark, Shimul Chowdhury, Shareef Nahas, Julie A Cakici, Wendy Benson, Robert H Kaplan, Richard Kronick,[...]. NPJ Genom Med 2018
126
11

Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
Christine Y Lu, Stephanie Loomer, Rachel Ceccarelli, Kathleen M Mazor, James Sabin, Ellen Wright Clayton, Geoffrey S Ginsburg, Ann Chen Wu. J Pers Med 2018
19
11

Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Glen R Monroe, Gerardus W Frederix, Sanne M C Savelberg, Tamar I de Vries, Karen J Duran, Jasper J van der Smagt, Paulien A Terhal, Peter M van Hasselt, Hester Y Kroes, Nanda M Verhoeven-Duif,[...]. Genet Med 2016
98
11

Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.
Kimberly Splinter, David R Adams, Carlos A Bacino, Hugo J Bellen, Jonathan A Bernstein, Alys M Cheatle-Jarvela, Christine M Eng, Cecilia Esteves, William A Gahl, Rizwan Hamid,[...]. N Engl J Med 2018
106
11

The burden of rare diseases.
Carlos R Ferreira. Am J Med Genet A 2019
41
11

Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico.
Alicia Scocchia, Kristen M Wigby, Diane Masser-Frye, Miguel Del Campo, Carolina I Galarreta, Erin Thorpe, Julia McEachern, Keisha Robinson, Andrew Gross, Subramanian S Ajay,[...]. NPJ Genom Med 2019
25
11

ACMG clinical laboratory standards for next-generation sequencing.
Heidi L Rehm, Sherri J Bale, Pinar Bayrak-Toydemir, Jonathan S Berg, Kerry K Brown, Joshua L Deignan, Michael J Friez, Birgit H Funke, Madhuri R Hegde, Elaine Lyon. Genet Med 2013
526
11

The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants.
Josh E Petrikin, Julie A Cakici, Michelle M Clark, Laurel K Willig, Nathaly M Sweeney, Emily G Farrow, Carol J Saunders, Isabelle Thiffault, Neil A Miller, Lee Zellmer,[...]. NPJ Genom Med 2018
72
11

Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases.
David Bick, Marilyn Jones, Stacie L Taylor, Ryan J Taft, John Belmont. J Med Genet 2019
24
11

Medicine. Brain disorders? Precisely.
Thomas R Insel, Bruce N Cuthbert. Science 2015
286
11

Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia.
Chelsea Lowther, Daniele Merico, Gregory Costain, Jack Waserman, Kerry Boyd, Abdul Noor, Marsha Speevak, Dimitri J Stavropoulos, John Wei, Anath C Lionel,[...]. Genome Med 2017
12
16

What are neurodevelopmental disorders?
Fatima Y Ismail, Bruce K Shapiro. Curr Opin Neurol 2019
14
14

1 in 38 individuals at risk of a dominant medically actionable disease.
Lonneke Haer-Wigman, Vyne van der Schoot, Ilse Feenstra, Anneke T Vulto-van Silfhout, Christian Gilissen, Han G Brunner, Lisenka E L M Vissers, Helger G Yntema. Eur J Hum Genet 2019
24
11

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Maria Schwaederle, Melissa Zhao, J Jack Lee, Alexander M Eggermont, Richard L Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock. J Clin Oncol 2015
219
11

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.
Tarjinder Singh, James T R Walters, Mandy Johnstone, David Curtis, Jaana Suvisaari, Minna Torniainen, Elliott Rees, Conrad Iyegbe, Douglas Blackwood, Andrew M McIntosh,[...]. Nat Genet 2017
84
11

Genomics in neurodevelopmental disorders: an avenue to personalized medicine.
Dora C Tărlungeanu, Gaia Novarino. Exp Mol Med 2018
21
11

Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges.
Gemma A Bilkey, Belinda L Burns, Emily P Coles, Faye L Bowman, John P Beilby, Nicholas S Pachter, Gareth Baynam, Hugh J S Dawkins, Kristen J Nowak, Tarun S Weeramanthri.  2019
9
22

Atypical cerebral palsy: genomics analysis enables precision medicine.
Allison M Matthews, Ingrid Blydt-Hansen, Basmah Al-Jabri, John Andersen, Maja Tarailo-Graovac, Magda Price, Katherine Selby, Michelle Demos, Mary Connolly, Britt Drögemoller,[...]. Genet Med 2019
16
12

Parents' perceptions of personal utility of exome sequencing results.
Lonna Mollison, Julianne M O'Daniel, Gail E Henderson, Jonathan S Berg, Debra Skinner. Genet Med 2020
11
18

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
Robert C Green, Katrina A B Goddard, Gail P Jarvik, Laura M Amendola, Paul S Appelbaum, Jonathan S Berg, Barbara A Bernhardt, Leslie G Biesecker, Sawona Biswas, Carrie L Blout,[...]. Am J Hum Genet 2016
96
11

Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy.
Mark A Corbett, Clare L van Eyk, Dani L Webber, Stephen J Bent, Morgan Newman, Kelly Harper, Jesia G Berry, Dimitar N Azmanov, Karen J Woodward, Alison E Gardner,[...]. NPJ Genom Med 2018
8
25

Chromosomal microarray impacts clinical management.
E R Riggs, K E Wain, D Riethmaier, B Smith-Packard, W A Faucett, N Hoppman, E C Thorland, V C Patel, D T Miller. Clin Genet 2014
51
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.